Form D · Other Health Care
Prenuvo, Inc.
Los Angeles, CA · CIK 0002028955
Offering snapshot reported Feb 14, 2025 · SEC filing
- Reported sold
- $85M Offering amount: $90M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2025 | Initial | $84,959,280 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-538366
Source: Form D, filed Feb 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| O'malley Brian | Director |
| Andrew Lacy | Director, Executive |
| Sundeep Peechu | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
12100 Wilshire Boulevard Ste 150
Los Angeles, CA, 90025
Los Angeles, CA, 90025